Bioinformatics Institute of India, as a part of its offerings to Pharma companies announces invitation for nomination of professionals for its January 2008 Batch – Industry Program in Pharma Regulatory Affairs. This program is specially meant for professionals working in the Pharmaceutical Industry and willing to specialize in the Pharma Regulatory Affairs . The program will have modules namely: Pharma Regulation Practices and Procedure, Pharma Patents, IPR and Regulation, Clinical Trials and Regulation, Pharma Regulation in USA, European Union , Good Manufacturing Practices, Quality Assurance and Regulation, Regulatory Compliance for Pharma and Biotech Products and Research Study. The program is delivered via BII’s proven distance participation methodology which includes dispatch of electronic lectures, study material and assignments, online support and interaction via BII Blog, placement support and all India exams . The past batches of this program have participants from reputed companies like Stride Arcolabs, Biocon, Ranbaxy, Dabur, Pfizer, Dr Reddy Labs, Vimta Labs, Novartis etc. So far more than 1000 professionals have participated in BII’s Pharma Regulatory Affairs program. Both group nomination from corporate HR Departments and individual nomination from professionals is invited. Highly interested BPharma / DPharma students in their final years are also welcome. Further details about the program are available at www.bii.in/biodlp, Last date to apply is January 31st 2008
Bioinformatics Institute of India, as a part of its offerings to Pharma companies announces invitation for nomination of professionals for its January 2008 Batch – Industry Program in Pharma Regulatory Affairs. This program is specially meant for professionals working in the Pharmaceutical Industry and willing to specialize in the Pharma Regulatory Affairs . The program will have modules namely: Pharma Regulation Practices and Procedure, Pharma Patents, IPR and Regulation, Clinical Trials and Regulation, Pharma Regulation in USA, European Union , Good Manufacturing Practices, Quality Assurance and Regulation, Regulatory Compliance for Pharma and Biotech Products and Research Study. The program is delivered via BII’s proven distance participation methodology which includes dispatch of electronic lectures, study material and assignments, online support and interaction via BII Blog, placement support and all India exams . The past batches of this program have participants from reputed companies like Stride Arcolabs, Biocon, Ranbaxy, Dabur, Pfizer, Dr Reddy Labs, Vimta Labs, Novartis etc. So far more than 1000 professionals have participated in BII’s Pharma Regulatory Affairs program. Both group nomination from corporate HR Departments and individual nomination from professionals is invited. Highly interested BPharma / DPharma students in their final years are also welcome. Further details about the program are available at www.bii.in/biodlp, Last date to apply is January 31st 2008
